Antoni Sureda1,2, Maria Del Mar Bibiloni1,2, Miquel Martorell1,3, Pilar Buil-Cosiales2,4, Amelia Marti2,4, Antoni Pons1,2, Josep A Tur1,2, Miguel Ángel Martinez-Gonzalez2,4. 1. Research Group on Community Nutrition and Oxidative Stress, University of Balearic Islands, Palma de Mallorca, Spain. 2. RD 06/0045 and CIBEROBN (Fisiopatología de la Obesidad y la Nutrición), Instituto de Salud Carlos III, Madrid, Spain. 3. Departamento de Nutrición y Dietética, Facultad de Farmacia, Universidad de Concepción, Concepción, Chile. 4. Department of Preventive Medicine and Public Health, School of Medicine, University of Navarra-IDISNA, Pamplona, Spain.
Abstract
SCOPE: This study assessed plasmatic antioxidant capabilities and xanthine oxidase (XOX) activity in metabolic syndrome patients after 5 years intervention with Mediterranean diet (MeDiet) supplemented withextra-virgin olive oil or with nuts or with low-fat diet (the PREDIMED [PREvención con Dieta MEDiterránea] study). METHODS AND RESULTS:Seventy-five participants were randomly selected. Daily energy and nutrient intake were assessed with a validated 137-item food frequency questionnaire, and adherence to the MeDiet was assessed using a 14-item questionnaire. Catalase, superoxide dismutase (SOD), myeloperoxidase, XOX activities and protein levels, and protein carbonyl derivatives, nitrotyrosine, nitrite and nitrate levels were determined in overnight fasting venous blood samples. The plasma activity and protein levels of SOD and catalase were significantly higher and XOX activity was lower in MeDiet supplemented with extra-virgin olive oil and MeDiet supplemented with nuts than in the control group. Participants in both MeDiet groups showed higher plasma nitrate levels than in the control group. Adherence to the MeDiet showed a positive correlation with SOD and catalase plasma antioxidant activities. CONCLUSION: A MeDiet enriched with either virgin olive oil or nuts enhances the plasma antioxidant capabilities and decreases XOX activity in patients with the metabolic syndrome but we did not observe changes in myeloperoxidase or markers of oxidative damage.
RCT Entities:
SCOPE: This study assessed plasmatic antioxidant capabilities and xanthine oxidase (XOX) activity in metabolic syndromepatients after 5 years intervention with Mediterranean diet (MeDiet) supplemented with extra-virgin olive oil or with nuts or with low-fat diet (the PREDIMED [PREvención con Dieta MEDiterránea] study). METHODS AND RESULTS: Seventy-five participants were randomly selected. Daily energy and nutrient intake were assessed with a validated 137-item food frequency questionnaire, and adherence to the MeDiet was assessed using a 14-item questionnaire. Catalase, superoxide dismutase (SOD), myeloperoxidase, XOX activities and protein levels, and protein carbonyl derivatives, nitrotyrosine, nitrite and nitrate levels were determined in overnight fasting venous blood samples. The plasma activity and protein levels of SOD and catalase were significantly higher and XOX activity was lower in MeDiet supplemented with extra-virgin olive oil and MeDiet supplemented with nuts than in the control group. Participants in both MeDiet groups showed higher plasma nitrate levels than in the control group. Adherence to the MeDiet showed a positive correlation with SOD and catalase plasma antioxidant activities. CONCLUSION: A MeDiet enriched with either virgin olive oil or nuts enhances the plasma antioxidant capabilities and decreases XOX activity in patients with the metabolic syndrome but we did not observe changes in myeloperoxidase or markers of oxidative damage.
Authors: Erika L Bettermann; Terryl J Hartman; Kirk A Easley; Erin P Ferranti; Dean P Jones; Arshed A Quyyumi; Viola Vaccarino; Thomas R Ziegler; Jessica A Alvarez Journal: J Nutr Date: 2018-02-01 Impact factor: 4.798
Authors: R Volpe; S Predieri; M Cianciabella; G M Daniele; E Gatti; M Magli; P Rodinò; E Schiavetto; G Sotis; S Urbinati Journal: Aging Clin Exp Res Date: 2020-08-07 Impact factor: 3.636
Authors: Brett M Frye; Suzanne Craft; Thomas C Register; Rachel N Andrews; Susan E Appt; Mara Z Vitolins; Beth Uberseder; Marnie G Silverstein-Metzler; Haiying Chen; Christopher T Whitlow; Jeongchul Kim; Richard A Barcus; Samuel N Lockhart; Siobhan Hoscheidt; Brandon M Say; Sarah E Corbitt; Carol A Shively Journal: Alzheimers Dement Date: 2020-12-03 Impact factor: 21.566